Quantum Biopharma Ltd. (QNTM) Form 6-K — Jun 2, 2026
Quantum BioPharma Ltd. has entered into a six-month investor relations and consulting services agreement with IR Agency LLC, operating under the Stocks.news brand. The agreement, effective June 8, 2026, involves a fee of US$250,000 for services including media distribution, digital community building, and lead generation campaigns. The filing confirms that the agency is arm’s-length and holds no equity interest in the company.
Key figures
- Ir agreement fee
- 250000
- Unbuzzd royalty cap usd
- 250000000
- Unbuzzd ownership percent
- 19.84
- Ir agreement duration months
- 6
- Unbuzzd royalty rate initial
- 7
- Unbuzzd royalty rate post cap
- 3
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.